HeartBeam

(NASDAQ) BEAT

Current Price$0.86

Market Cap$48.36M

Since IPO (2021)-81%

5 YearN/A

1 Year-52%

1 Month-23%

HeartBeam Financials at a Glance

Market Cap

$48.36M

Revenue (TTM)

$0.00

Net Income (TTM)

$21.02M

EPS (TTM)

$-0.63

P/E Ratio

-1.39

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$0.86

Volume

5,667

Open

$0.88

Price

$0.86

Volume

5,667

Open

$0.88

Previous Close

$0.86

Daily Range

$0.85 - $0.88

52-Week Range

$0.54 - $4.00

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$0.86

Volume

5,667

Open

$0.88

Previous Close

$0.86

Daily Range

$0.85 - $0.88

52-Week Range

$0.54 - $4.00

BEAT News

HeartBeam Cuts Costs Awaits FDA Decision

Motley Fool Markets TeamAug 13, 2025

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About HeartBeam

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

CEO

Robert P. Eno, MBA

Website

www.heartbeam.com

Headquarters

Santa Clara, CA 95050, US

BEAT Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-987%

Return on Capital

-8%

Return on Assets

-4%

Earnings Yield

-71.94%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$48.36M

Shares Outstanding

55.51M

Volume

5.67K

Avg. Volume

1.46M

Financials (TTM)

Gross Profit

$40.00K

Operating Income

$21.14M

EBITDA

$21.14M

Operating Cash Flow

$13.99M

Capital Expenditure

$600.00K

Free Cash Flow

$14.59M

Cash & ST Invst.

$4.38M

Total Debt

$0.00

HeartBeam Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$8.00K

N/A

Gross Margin

0.00%

N/A

Market Cap

$48.36M

N/A

Market Cap/Employee

$2.30M

N/A

Employees

N/A

Net Income

$5.30M

-8.0%

EBITDA

$5.29M

-7.1%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$4.38M

+84.3%

Accounts Receivable

$0.00

N/A

Inventory

$103.00K

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-3.60%

N/A

Return on Invested Capital

-8.12%

N/A

Free Cash Flow

$3.32M

+20.0%

Operating Cash Flow

$2.91M

+30.0%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

INKTMiNK Therapeutics, Inc.

INKTMiNK Therapeutics, Inc.$11.81+8.55%

ONMDOneMedNet Corporation

ONMDOneMedNet Corporation$1.08-0.92%

MDAISpectral AI, Inc.

MDAISpectral AI, Inc.$1.94-2.02%

CRVOCervoMed Inc.

CRVOCervoMed Inc.$3.65-1.62%

HOWLWerewolf Therapeutics, Inc.

HOWLWerewolf Therapeutics, Inc.$0.68-8.11%

OSTXOS Therapies Incorporated

OSTXOS Therapies Incorporated$1.63+0.00%

EQEquillium, Inc.

EQEquillium, Inc.$2.08+1.46%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

INTCIntel

INTCIntel$94.75+0.12%

NOKNokia

NOKNokia$12.46+0.10%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.14+0.04%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$61.86+0.02%

KALVKalVista Pharmaceuticals

KALVKalVista Pharmaceuticals$26.67+0.39%

POETPoet Technologies

POETPoet Technologies$6.60-0.18%

ONDSOndas

ONDSOndas$9.49-0.09%

Questions About BEAT

What is the current price of HeartBeam?

HeartBeam is trading at $0.86 per share.

What is the 52-week range for HeartBeam?

Over the past 52 weeks, HeartBeam has traded between $0.54 and $4.00.

How much debt does HeartBeam have?

As of the most recent reporting period, HeartBeam reported total debt of N/A.

How much cash does HeartBeam have on hand?

HeartBeam reported $4.38M in cash and cash equivalents in its most recent financial results.

What is HeartBeam’s dividend yield?

HeartBeam does not currently have a dividend yield.

HeartBeam

HeartBeam Financials at a Glance

BEAT News

HeartBeam Cuts Costs Awaits FDA Decision

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About HeartBeam

BEAT Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

HeartBeam Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About BEAT

What is the current price of HeartBeam?

What is the 52-week range for HeartBeam?

How much debt does HeartBeam have?

How much cash does HeartBeam have on hand?

What is HeartBeam’s dividend yield?

Premium Investing Services